Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia.
Central pontine myelinolysis in a case of alcohol dependence syndrome.
Acute Disseminated Encephalomyelitis After Influenza Vaccination: A Case Report.
Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.
Development and feasibility of the Help to Overcome Problems Effectively (HOPE) self-management intervention for people living with multiple sclerosis.
Influenza vaccination in patients with multiple sclerosis is possible with some considerations.
Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
Immediate effect of two yoga-based relaxation techniques on cognitive functions in patients suffering from relapsing remitting multiple sclerosis: A comparative study.
Imaging of progressive weakness or numbness of central or peripheral origin.
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab.
A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives.
ASSOCIATION BETWEEN DISABILITY AND QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS IN AHVAZ, IRAN.
Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.
Aescin reduces oxidative stress and provides neuroprotection in experimental traumatic spinal cord injury.
Poster 378 Transverse Myelitis Secondary to Infectious Mononucleosis: A Case Report.
Yellow fever vaccine-associated neurotropic disease (YEL-AND) - A case report.
Olig2-Targeted G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Survival in Response to Lysolecithin-Induced Demyelination.
Is Time to Reach EDSS 6.0 Faster in Patients with Late-Onset versus Young-Onset Multiple Sclerosis?
Estimating epidemiological data of Multiple sclerosis using hospitalized data in Shandong Province, China.
CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis.
Pages
« first
‹ previous
…
842
843
844
845
846
847
848
849
850
…
next ›
last »